newsfilter
← Latest News
GlobeNewswire·

Otonomy Announces Presentation of OTO-313 Clinical Results at American Neurotology Society Annual Meeting

SAN DIEGO, April 05, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced the...